Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different OutcomesDaniela Sia, Josep M. Llovet, Helena Cornellà et al.|Gastroenterology|2013Cited by 597
Combining Clinical, Pathology, and Gene Expression Data to Predict Recurrence of Hepatocellular CarcinomaAugusto Villanueva, Josep M. Llovet, Yujin Hoshida et al.|Gastroenterology|2011Cited by 466
Massive parallel sequencing uncovers actionable FGFR2–PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinomaDaniela Sia, Josep M. Llovet, Bojan Losic et al.|Nature Communications|2015Cited by 302
BASIC AND TRANSLATIONAL—BILIARY Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different OutcomesDaniela Sia, Josep M. Llovet, Yujin Hoshida et al.|Unknown|2013Cited by 0
Abstract #444: Molecular and clinical characterization of RICTOR (MTORC2) as a candidate oncogene in hepatocellular carcinomaAugusto Villanueva, Josep M. Llovet, Helena Cornellà et al.|Cancer Research|2009Cited by 0